Vasotechnology, Inc., a leading innovator in the vascular technology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2010, the company has rapidly established itself as a key player in the medical device industry, focusing on advanced solutions for vascular access and management. Vasotechnology's core offerings include state-of-the-art vascular access devices and innovative monitoring systems, designed to enhance patient outcomes and streamline clinical workflows. Their commitment to quality and innovation has earned them recognition for excellence in product design and functionality. With a strong market position, Vasotechnology has achieved notable milestones, including multiple industry awards and partnerships with leading healthcare institutions. Their unique approach to vascular technology continues to set them apart, making them a trusted name in the field.
How does Vasotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vasotechnology, Inc.'s score of 5 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vasotechnology, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Vaso Corporation, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Vasotechnology, Inc., it is important to note that emissions data and climate initiatives may be inherited from its parent company, Vaso Corporation. This relationship suggests that any climate strategies or emissions reductions may align with the broader goals set by Vaso Corporation. As of now, Vasotechnology, Inc. has not established specific science-based targets or commitments to reduce emissions, nor has it reported any significant achievements in this area. The lack of data highlights an opportunity for the company to enhance its climate strategy and transparency in emissions reporting.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vasotechnology, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.